Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Robert B. Kammer"'
Autor:
Richard D. Meyer, Jack S. Remington, Anthony W. Chow, Robert B. Kammer, Caroline B. Hall, Jerome O. Klein
Publikováno v:
Clinical Infectious Diseases. 15:S62-S88
These guidelines deal with the evaluation of anti-infective drugs for the treatment of respiratory tract infections. Five clinical entities are described: streptococcal pharyngitis and tonsillitis, otitis media, sinusitis, bronchitis, and pneumonia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::870e05160c7c77359e083c4a36b9237c
https://doi.org/10.1093/clind/15.supplement_1.s62
https://doi.org/10.1093/clind/15.supplement_1.s62
Autor:
Robert B. Kammer, Rudyard Joseph Ress
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 14:101-105
In a randomized, single-blind trial, ceftibuten in doses of 200 mg and 300 mg administered b.i.d., was compared with cefaclor 500 mg t.i.d. in acute lower respiratory tract infections. A total 545 patients were enrolled, of which 263 were evaluable f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a70e5bc6469502521ebc5df822a6246
https://doi.org/10.1016/0732-8893(91)90097-y
https://doi.org/10.1016/0732-8893(91)90097-y
Autor:
Robert B. Kammer
Publikováno v:
Clinical Infectious Diseases. 4:S712-S719
The efficacy and safety of moxalactam disodium were studied by 173 investigators in the United States. Of 3,558 adult and pediatric patients who were treated for various infections, 2,234 met all protocol requirements for evaluation of efficacy of tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37c442952f1dfed1cc7e10ff61346ba5
https://doi.org/10.1093/clinids/4.supplement_3.s712
https://doi.org/10.1093/clinids/4.supplement_3.s712
Autor:
Robert B. Kammer, John P. Utz
Publikováno v:
The American Journal of Medicine. 56:506-521
Aspergillus flavus endocarditis developed in a 13 year old girl after mitral valve replacement. Thirty-nine other cases of Aspergillus species endocarditis were found in the medical literature. Twenty-nine of these infections occurred in postcardiac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24fa6e704b296b5cfb435c6aa4de2446
https://doi.org/10.1016/0002-9343(74)90483-5
https://doi.org/10.1016/0002-9343(74)90483-5
Autor:
Robert B. Kammer, Nils U. Bang
Publikováno v:
Clinical Infectious Diseases. 5:S380-S393
Antibiotics of the p-lactam class can adversely affect the function of blood components in a variety of ways. Through immune mechanisms these antibiotics can cause destruction of erythrocytes, leukocytes, and platelets. These events are rare and usua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65fe3a8eecaca672eb57309da54ebedf
https://doi.org/10.1093/clinids/5.supplement_2.s380
https://doi.org/10.1093/clinids/5.supplement_2.s380
Autor:
John C. Sherris, Robert B. Kammer, John A. Washington, Arthur L. Barry, Clyde Thornsberry, Fritz D. Schoenknect, Smith Shadomy
Publikováno v:
American Journal of Clinical Pathology. 72:858-860
By use of an agardilution technic, 1,881 clinical isolates were tested against cefamandole and cephalothin. The isolates represented 18 genera, recovered in five geographically separate centers within the United States. The majority of strains were s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efb952bb3ec7ecce7981fe12f8d7f1c2
https://doi.org/10.1093/ajcp/72.5.858
https://doi.org/10.1093/ajcp/72.5.858
Autor:
Robert B. Kammer
Publisher Summary This chapter discusses the changing clinical role of various β-lactam antibiotics against a historical pattern. These compounds are evaluated in vitro against a variety of clinical pathogens to determine which compounds possess the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ef168bc14a62a2f2144f5a13b1f8328
https://doi.org/10.1016/b978-0-12-506303-6.50010-8
https://doi.org/10.1016/b978-0-12-506303-6.50010-8
Autor:
Robert B. Kammer
Publikováno v:
The Annals of otology, rhinologylaryngology. Supplement. 90(3 Pt 3)
Cefaclor, a semisynthetic cephalosporin antibiotic for oral use, was studied by 62 clinical investigators in six countries in 3,084 adult and pediatric patients. The pooled data reveal that satisfactory clinical responses were obtained in 96% of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::772c02568f5031331365efca7ffbdac9
https://pubmed.ncbi.nlm.nih.gov/6791569
https://pubmed.ncbi.nlm.nih.gov/6791569
Ampicillin-resistant and -susceptible strains of Haemophilus influenzae were tested for susceptibility to 16 antibiotics. Chloramphenicol and a new cephalosporin, cefamandole, were most active with minimal inhibitory concentrations (MICs) for all bac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::732582975de52584d84c3dd009e42b4c
https://europepmc.org/articles/PMC429266/
https://europepmc.org/articles/PMC429266/
Publikováno v:
JAMA: The Journal of the American Medical Association. 245:2027-2028
To the Editor.— The letter describing disulfiram-like reactions in subjects taking cefoperazone (1980;243:2397) asked (1) "Which other cephalosporins might also produce this reaction?" and (2) "Is acetaldehyde increased during these reactions?" In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::faaf9bbba399f128240c6606ee728386
https://doi.org/10.1001/jama.1981.03310450021011
https://doi.org/10.1001/jama.1981.03310450021011